Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scheer

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Nucleic Acids Research|January 10, 2003
TRANSFAC: transcriptional regulation, from patterns to profilesV Matys, E Fricke, R Geffers, et al.
Mabs|August 31, 2017
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eyeDevin Tesar, Jacob Luoma, Emily A Wyatt, et al.
The Journal of Biological Chemistry|May 7, 2010
Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signalingJanet Jackman, Yongmei Chen, Arthur Huang, et al.
Cancer Research|September 18, 2014
Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cellsTeemu T Junttila, Ji Li, Jennifer Johnston, et al.
The Journal of Biological Chemistry|July 25, 2013
Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokinesChristoph Spiess, Jack Bevers, Janet Jackman, et al.
Mabs|May 25, 2022
An adapted consensus protein design strategy for identifying globally optimal biotherapeuticsYanyun Liu, Kenny Tsang, Michelle Mays, et al.
Science Translational Medicine|May 15, 2015
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignanciesLiping L Sun, Diego Ellerman, Mary Mathieu, et al.
Med (New York, N.Y.)|October 18, 2022
Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosisSuzanne Edavettal, Pilar Cejudo-Martin, Bidisha Dasgupta, et al.
Hamostaseologie|June 7, 2014
[Diagnosis of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]R Knöfler, W Eberl, H Schulze, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Nucleic Acids Research|January 10, 2003
TRANSFAC: transcriptional regulation, from patterns to profilesV Matys, E Fricke, R Geffers, et al.
Mabs|August 31, 2017
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eyeDevin Tesar, Jacob Luoma, Emily A Wyatt, et al.
The Journal of Biological Chemistry|May 7, 2010
Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signalingJanet Jackman, Yongmei Chen, Arthur Huang, et al.
Cancer Research|September 18, 2014
Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cellsTeemu T Junttila, Ji Li, Jennifer Johnston, et al.
The Journal of Biological Chemistry|July 25, 2013
Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokinesChristoph Spiess, Jack Bevers, Janet Jackman, et al.
Mabs|May 25, 2022
An adapted consensus protein design strategy for identifying globally optimal biotherapeuticsYanyun Liu, Kenny Tsang, Michelle Mays, et al.
Science Translational Medicine|May 15, 2015
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignanciesLiping L Sun, Diego Ellerman, Mary Mathieu, et al.
Med (New York, N.Y.)|October 18, 2022
Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosisSuzanne Edavettal, Pilar Cejudo-Martin, Bidisha Dasgupta, et al.
Hamostaseologie|June 7, 2014
[Diagnosis of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]R Knöfler, W Eberl, H Schulze, et al.
Pageof 15